CLOROX CO /DE/

The Clorox Company

Overview

The Clorox Company is a multinational manufacturer and marketer of consumer and professional products. Its portfolio includes flagship brands across cleaning, household, lifestyle, and health/wellness categories, plus professional products. Products are sold primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home centers, drug/pet/military stores, e-commerce, and distributors.

Financial snapshot (fiscal year 2026)

• Net sales: approximately $6.7 billion.
• Employees: about 9,200 worldwide as of June 30, 2026.
• Geographic reach: operations in roughly 25 countries/territories; products sold in about 95 markets.
• U.S. vs. international: ~84% of net sales from U.S. markets; ~16% from international markets.
• Dividends: paid $602 million in dividends during fiscal 2026; announced a 1% dividend increase in July 2026.
• Earnings: diluted net earnings per share decreased 26% versus the prior year, driven by lower net sales and higher manufacturing and logistics costs, partially offset by lapping the loss from the divestiture of the Better Health VMS business.

Major customers

• Largest customer: Walmart Stores, Inc. and affiliates, accounting for 26% of consolidated net sales in fiscal 2026 (27% in 2025; 25% in 2024).
• The five largest customers accounted for about half of consolidated net sales in each of 2026, 2025, and 2024.

Recent major developments

• GOJO acquisition: Completed April 1, 2026. GOJO now operates as Clorox Purell, expanding the health and hygiene portfolio and B2B channels (healthcare and institutional markets) with an established distribution network and dispensing systems.
• Glad joint venture: The Procter & Gamble venture expired January 31, 2026. Clorox acquired P&G’s 20% interest for cash (approximately $476 million) and now operates Glad as a standalone business with royalty-free core IP licenses for licensed products.
• Integration and transformational investments: ERP system replacement completed January 2026. Total incremental transformational investment was about $580 million to improve supply chain, digital commerce, innovation, and portfolio execution.
• 2026 product launches and portfolio expansion: Clorox PURE and Clorox Screen+ Sanitizing Wipes; expanded professional hygiene solutions (Clorox Healthcare and Purell); Fresh Step Lightweight Litter; Glad ForceFlex MaxStrength LeakGuard Trash Bags; new Burt’s Bees lip and body care offerings; new flavors and scents across Clorox, Glad, Hidden Valley Ranch, and Pine-Sol.
• Acquisition-related impact: The GOJO acquisition increased debt, resulting in higher interest expense and integration risk. Go-to-market and channel integration with Purell’s B2B model is a key integration focus.

Business segments

Clorox reports four operating segments:

• Health and Wellness: U.S.-focused cleaning, disinfecting, sanitizing, and professional products, including Clorox, Pine-Sol, Liquid-Plumr, Formula 409; Purell and GOJO brands in skin sanitization and cleaning; professional offerings under CloroxPro and Clorox Healthcare. Hidden Valley (food-service) is included here.
• Household: U.S.-focused bags and wraps (Glad), cat litter (Fresh Step, Scoop Away), and Kingsford grilling products.
• Lifestyle: U.S.-focused food, water-filtration, and natural personal care; Hidden Valley dressings, dips, seasonings, and sauces; Brita water-filtration products; Burt’s Bees personal care.
• International: Products sold outside the U.S., including laundry additives, home care (Poett, Pine-Sol, Clorinda, Chux), Glad bags/wraps, Ever Clean/Fresh Step cat litter, and Brita abroad.
• Corporate and Other: consolidates unallocated corporate items.

Principal products and revenue mix (FY2026, illustrative)

• Cleaning products: 44% of consolidated net sales.
• Bags and wraps: 15%.
• Food products: 11%.
• Cat litter products: 10%.

Brands and capabilities

• Consumer brands: Clorox, Pine-Sol, Liquid-Plumr, Poett, Glad, Fresh Step, Kingsford, Hidden Valley, Brita, Burt’s Bees.
• Professional brands: Purell (via GOJO / Clorox Purell), CloroxPro, Clorox Healthcare.
• Licensing and ownership: GOJO operates as Clorox Purell post-acquisition; Glad is fully owned by Clorox with royalty-free core IP licenses in place for licensed products.

Market positioning and strategy

• Strategy framework (IGNITE): Four strategic choices focused on long-term, profitable growth through product innovation, consumer experiences, workforce and operational transformation, and portfolio evolution, with sustainability embedded across initiatives.
• Growth approach: portfolio expansion through acquisitions and new product introductions, portfolio optimization, and a streamlined operating model.
• Supplier and channel dynamics: substantial reliance on large retailers (for example, Walmart) and a mix of direct sales, brokers, and distributors; ongoing integration of GOJO and potential channel conflicts with standalone Glad operations.

Operations and sustainability

• ERP implementation completed; ongoing optimization and integration with acquired businesses (including GOJO) to improve supply chain, digital capabilities, and operating efficiency.
• Emphasis on sustainability, safety, and governance as part of enterprise strategy and operations.

Debt and credit (as of June 30, 2026)

• Total debt: approximately $5.1 billion.
• Recent financing activity supported the GOJO and Glad transactions. S&P lowered the long-term rating to BBB from BBB+ in February 2026; both ratings remain investment grade.
• Higher leverage and interest costs are associated with recent acquisitions, which may affect liquidity and financial flexibility.

Executive leadership (selected)

• CEO and Chair: Linda Rendle (Chair since January 2024; CEO since September 2020).
• Other executive officers are listed in the company filing.